Nanoengineers at the University of California San Diego have developed a computer-based method that could make it less labor-intensive to determine the crystal structures of various materials and molecules, including alloys, proteins and pharmaceuticals. The method uses a machine learning a ... more
An errant editing enzyme promotes tumor suppressor loss and leukemia propagation
Researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Adenosine deaminases are a family of three enzymes encoded by the ADAR genes, which stand for adenosine deaminase acting on RNA. They regulate gene expression by modifying nucleotides within double stranded RNA molecules, serving as fundamental editors in the development of new stem cells.
The enzyme, however, is also activated in cancers as diverse as liver, breast and leukemia. A research team led by senior author Catriona Jamieson, MD, PhD, deputy director of the Sanford Stem Cell Clinical Center and deputy director of the UC San Diego Moores Cancer Center, found that the normal functions of the ADAR1 enzyme are hijacked by pre-malignant cells, leading to a cascade of molecular consequences that promote malignant transformation, dormant cancer stem cell generation and resistance to treatment.
"We were able to illuminate the abilities of ADAR1 to 'hyper-mutate' tumor suppressor RNAs in leukemia and, at the same time, edit the microRNA aimed at targeting the tumor suppressor RNA. This enzyme turns on cancer resistance via a domino effect on RNA instead of DNA," said first author Qingfei Jiang, PhD, assistant project scientist in Jamieson's lab.
Jamieson characterized RNA editing as tweaking basic genetic blueprints, not fundamentally rewriting them. Nonetheless, the results might be dramatic. "One result of detection of malignant RNA editing could be exposing dormant cancer stem cells that often escape therapies that target dividing cells, which leads to therapeutic resistance and disease relapse, and also highlight ADAR as a potentially tractable target for cancer stem cell elimination," said Jamieson.
- UC San Diego
- stem cells
- gene expression
- cancer stem cells
- adenosine deaminases
By stacking and connecting layers of stretchable circuits on top of one another, engineers have developed an approach to build soft, pliable "3D stretchable electronics" that can pack a lot of functions while staying thin and small in size. As a proof of concept, a team led by the Universit ... more
By doping alumina crystals with neodymium ions, engineers at the University of California San Diego have developed a new laser material that is capable of emitting ultra-short, high-power pulses--a combination that could potentially yield smaller, more powerful lasers with superior thermal ... more
A team of mechanical engineers at the University of California San Diego has successfully used acoustic waves to move fluids through small channels at the nanoscale. The breakthrough is a first step toward the manufacturing of small, portable devices that could be used for drug discovery an ... more
- 1Virtual screening for active substances against the coronavirus
- 2analytica 2020 is postponed
- 3FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing
- 4Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization
- 5The digital laboratory live and tangible
- 6Smartphone lab finds coronavirus in saliva
- 7Thermo Fisher Scientific to Acquire QIAGEN
- 8Pool testing of SARS-CoV-02 samples increases worldwide test capacities many times over
- 9Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
- 10Bosch develops rapid test for COVID-19
- New blood test detects wide range of cancers
- Staining Cycles with Black Holes
- FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing
- New device quickly detects harmful bacteria in blood
- Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus